Explore more Johnson & Johnson sites:
Learn More About Janssen's Phase 3 COVID-19 Vaccine Candidate Clinical Trials Here
Learn More
Share
Johnson & Johnson by the Numbers
Learn more about how we care for the world—one person at a time—through these company fast facts.
Alex Gorsky assumed his current position as Chairman and CEO of Johnson & Johnson in 2012. He is the ninth leader of Johnson & Johnson since it was founded in 1886. Learn more about Alex and our leadership team.
In 2017, Johnson & Johnson opened the doors to Our Story at the Power House, a state-of-the-art physical exhibition at our world headquarters. The company also launched an interactive museum—ourstory.jnj.com— that celebrates over 130 years of innovations that have changed the course of human health.
We operate Johnson & Johnson Innovation, JLABS health sciences incubators in nine North American and European locales; JLABS @ Shanghai will open in 2019.
Johnson & Johnson’s consumer brands are often the first and most personal experience people have with our company. Our baby care, beauty, oral care, self-care, women’s health and wound care brands have been trusted by consumers and healthcare professionals for more than 100 years.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we’re creating a future where disease is a thing of the past. We work tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
As the world’s most comprehensive medical devices business, we leverage our expertise across eye health, interventional solutions, orthopaedics and surgery.
More From Johnson & Johnson
November 17, 2020
The novel coronavirus has exposed deeply rooted disparities across the healthcare system which disproportionately impact communities of color. The way to begin to pave the way for lasting change? Inclusive innovation, community outreach and policy work—and a passion for fighting for an equitable future.
November 10, 2020
Njira Lugogo, M.D., is a pulmonologist at the University of Michigan who is leading a clinical study of an investigational COVID-19 vaccine candidate. She helps answer common questions people may have about the process, from what people over 60 need to know to how participants are being kept safe during the pandemic.
September 23, 2020
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
